Resúmenes Epistemonikos
Medwave 2015 Jul;15(Suppl 1):e6179 doi: 10.5867/medwave.2015.6179
¿Sirve agregar azatioprina a los corticoides en pacientes con polimiositis?
What are the effects of adding azathioprine to corticosteroids in polymyositis?
Cristina Meneses, Gabriel Rada
Referencias | Descargar PDF |
Para Descargar PDF debe Abrir sesión.
Imprimir | A(+) A(-) | Lectura fácil

Abstract

The treatment of polymyositis is based on corticosteroid therapy, with addition of azathioprine for non responsive cases or as an attempt to diminish corticosteroids requirements. However, there is no clear evidence of its benefit in controlling symptoms. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified only one systematic review including one pertinent randomized trial. We generated a summary of findings following the GRADE approach. We concluded there is uncertainty if azathioprine improves or not muscular strength in polymyositis because the certainty of the evidence is very low.


 
Problem

Corticosteroids constitute the standard treatment for dermatomyositis and polymyositis. Given their multiple short and long term side effects there is interest in other immunomodulators, such as azathioprine, especially for non-responsive cases or as an attempt to diminish corticosteroids requirements. However, there is no clear evidence of its  benefit in controlling symptoms, and it also carry important side effects.

Methods

We used Epistemonikos database, which is maintained by screening more than 30 databases, to identify systematic reviews and their included primary studies. With this information we generated a structured summary using a pre-established format, which includes key messages, a summary of the body of evidence (presented as an evidence matrix in Epistemonikos), a summary of findings table following the GRADE approach and a table of other considerations for decision-making.

Key messages

  • There is uncertainty if azathioprine improves or not muscular strength in polymyositis because the certainty of the evidence is very low.
  • As far as we know there are no ongoing trials evaluating this question

About the body of evidence for this question

What is the evidence.
See evidence matrix  in Epistemonikos later

We found one systematic review [1] including only one pertinent randomized controlled trial [2].

What types of patients were included

The study included adults with polymyositis diagnosed with Bohan and Peter criteria and positive muscle biopsy

Patients with previous corticosteroid or immunosuppresive therapy were excluded.  

What types of interventions were included

Azathioprine 2mg/kg qd plus prednisone 60 mg qd, compared with prednisone 60 mg qd.

What types of outcomes were measured

Improvement in muscular strength evaluated in each muscular group (score  from 0= no deficit, to -140= maximum deficit), serum creatine kinase, muscular biopsy (0= normal, to 36= maximum inflammation).

Summary of findings

The information on the effects of azathioprine is based on one randomized controlled trial [2] including 16 patients.

  •  There is uncertainty if azathioprine improves or not muscular strength in polymyositis. The certainty of the evidence is very low.


Other considerations for decision-making

To whom this evidence does and does not apply

  • The study included patients with polymyositis meeting Bohan and Peter criteria, so the evidence found is applied directly to this group. It is clinically reasonable to extend this findings to patients with dermatomyositis with muscular involvement. 
  • It does not clearly apply to pediatric patients or patients with other rheumatologic diagnosis or presenting overlap syndrome.
About the outcomes included in this summary
  • The outcomes presented are those considered critical for decision-making, according to the authors of this summary. We did not find clinical guidelines or studies about the relative importance of the outcomes for this condition. 
Balance between benefits and risks, and certainty of the evidence
  • It is not possible to estimate the risk/benefit given the existing uncertainty. Considering the intervention has side effects and costs its use outside of the context of a clinical trial is questionable.
What would patients and their doctors think about this intervention
  • Given the absence of a clearly established alternative treatment, it is possible some clinicians will consider using this drug, especially in refractory patients. Some patients putting more value on the hypothetical benefit than on the risks and costs, may be inclined to use it too. In these cases, it is extremely important to inform the patient about the certainty of the evidence.  
Resource considerations
  • Given the uncertainty about the benefits, it is not possible to make a judgment about the cost/benefit.

Differences between this summary and other sources

  • Our summary is in agreement with the only systematic review identified. 
  • We did not identify guidelines that are recognized by a substantial proportion of experts in the topic.
Could this evidence change in the future?
  • The probability of this information changing with new studies is very high because the certainty of the evidence is very low. 
  • Unfortunately, we did not identify any ongoing study addressing this question.

How we conducted this summary

Using automated and collaborative means, we compiled all the relevant evidence for the question of interest and we present it as a matrix of evidence.

Matrix of evidence (static version)

Follow the link to access the interactive version Corticosteroids plus azathioprine versus corticosteroids alone for polymyositis

Notes

The upper portion of the matrix of evidence will display a warning of “new evidence” if new systematic reviews are published after the publication of this summary. Even though the project considers the periodical update of these summaries, users are invited to comment in Medwave or to contact the authors through email if they find new evidence and the summary should be updated earlier. After creating an account in Epistemonikos, users will be able to save the matrixes and to receive automated notifications any time new evidence potentially relevant for the question appears.

The details about the methods used to produce these summaries are described here http://dx.doi.org/10.5867/medwave.2014.06.5997.

Epistemonikos foundation is a non-for-profit organization aiming to bring information closer to health decision-makers with technology. Its main development is Epistemonikos database (www.epistemonikos.org).

These summaries follow a rigorous process of internal peer review.

Conflicts of interest
The authors do not have relevant interests to declare.

Matrix of evidence (static version)
Licencia Creative Commons Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

 

The treatment of polymyositis is based on corticosteroid therapy, with addition of azathioprine for non responsive cases or as an attempt to diminish corticosteroids requirements. However, there is no clear evidence of its benefit in controlling symptoms. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified only one systematic review including one pertinent randomized trial. We generated a summary of findings following the GRADE approach. We concluded there is uncertainty if azathioprine improves or not muscular strength in polymyositis because the certainty of the evidence is very low.

Autores: Cristina Meneses[1,2], Gabriel Rada[1,2,3,4,5,6]

Filiación:
[1] Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
[2] Proyecto Epistemonikos
[3] Programa de Salud Basada en Evidencia, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
[4] Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
[5] GRADE working group
[6] The Cochrane Collaboration

E-mail: radagabriel@epistemonikos.org

Correspondencia a:
[1] Facultad de Medicina
Pontificia Universidad Católica de Chile
Lira 63
Santiago Centro
Chile

Citación: Meneses C, Rada G. What are the effects of adding azathioprine to corticosteroids in polymyositis?. Medwave 2015 Jul;15(Suppl 1):e6179 doi: 10.5867/medwave.2015.6179

Fecha de publicación: 8/7/2015

Ficha PubMed

Comentarios (0)

Nos complace que usted tenga interés en comentar uno de nuestros artículos. Su comentario será publicado inmediatamente. No obstante, Medwave se reserva el derecho a eliminarlo posteriormente si la dirección editorial considera que su comentario es: ofensivo en algún sentido, irrelevante, trivial, contiene errores de lenguaje, contiene arengas políticas, obedece a fines comerciales, contiene datos de alguna persona en particular, o sugiere cambios en el manejo de pacientes que no hayan sido publicados previamente en alguna revista con revisión por pares.

Aún no hay comentarios en este artículo.


Para comentar debe iniciar sesión

Medwave publica las vistas HTML y descargas PDF por artículo, junto con otras métricas de redes sociales.

Se puede producir un retraso de 48 horas en la actualización de las estadísticas.

  1. Gordon PA, Winer JB, Hoogendijk JE, Choy EH. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev. 2012 Aug 5;8:CD003643. | CrossRef | PubMed |
  2. Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG. Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med. 1980 Mar;92(3):365-9. | PubMed |
Gordon PA, Winer JB, Hoogendijk JE, Choy EH. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev. 2012 Aug 5;8:CD003643. | CrossRef | PubMed |

Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG. Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med. 1980 Mar;92(3):365-9. | PubMed |